ELYM Overview
Upcoming Projects (ELYM)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ELYM)
-
Discussing primary Membranous Nephropathy and the potential of Eliem Therapeutics' TNT119, an anti-CD19 mAB
Ticker: ELYM
Executed On: Sep 09, 2024 at 05:00 PM EDT -
A Second Look: Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: ARGX, AMGN, ELYM
Executed On: Aug 29, 2024 at 12:30 PM EDT -
Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: ARGX, AMGN, ELYM
Executed On: Aug 28, 2024 at 01:00 PM EDT -
Discussing the potential of CD19 targeted therapies in systemic lupus erythematosus (SLE)
Tickers: AMGN, CGEM, ELYM, CABA
Executed On: Jul 19, 2024 at 12:30 PM EDT
Expired Projects (ELYM)
-
A third Look: Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: AMGN, ARGX, ELYM
Execute By: Sep 19, 2024
Upcoming & Overdue Catalysts (ELYM)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ELYM)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
